NTLAIntellia Therapeutics, Inc.

$13.19

What is the market doing?

What the tape says about NTLA

Intellia Therapeutics, Inc. is +15% over the past year while the S&P 500 is +23%: 7.5 points behind the market.

+15%

1-year return · S&P 500 +23%

vs 200-day average
+5.8%

vs 200-day average · close to trend

RSI (14)
64

RSI (14) · neutral

Below its 52-week high
−53%

Below its 52-week high

2024-08-06$6.28 – $27.98 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$13.19
1 monthS&P 500 +3.7%
+19%
1 yearS&P 500 +23%
+15%
5 yearsS&P 500 +87%
−90%
vs 50-day average$12.80
+3.1%
52-week high
$27.98
52-week low
$8.04
Annualised volatility
90%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
$605K
Calendar-year price return
YearReturn
2026 (year to date)+47%
2025−23%
2024−62%
2023−13%
2022−70%
2021+117%
2020+271%
2019+7.5%
2018−29%
2017+47%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan105 of 10+4.7%
Feb107 of 10+6.5%
Mar102 of 10−6.9%
Apr105 of 10−2.9%
May103 of 10+0.64%
Jun1010 of 10+27%
Jul116 of 11+1.1%
Aug116 of 11+3.8%
Sep102 of 10−1.1%
Oct102 of 10−11%
Nov106 of 10+7.8%
Dec103 of 10−8.4%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.